France· FR:66843357
ERBITUX 5 mg/ml, solution pour perfusion
A medicinal product containing cétuximab, registered in France by MERCK KGAA (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CÉTUXIMAB
- Manufacturer
- MERCK KGAA (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009570750881 flacon(s) en verre de 20 ml
- cip1334009570752001 flacon(s) en verre de 100 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cétuximab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsErbitux 5 mg/ml, oplossing voor infusieMerck Europe B.V.
- FinlandErbituxMerck KGaA
- United KingdomErbitux 100mg/20ml solution for infusion vialsMerck Serono Ltd
- CzechiaERBITUXMerck Europe B.V., Amsterdam
- BelgiumErbitux 5 mg/mlMerck Europe
- SwitzerlandErbitux
- Japanセツキシマブ（遺伝子組換え）メルクバイオファーマ
- SwedenErbitux 2 mg/ml Infusionsvätska, lösningMerck Germany
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Erbitux
- Liechtenstein · Erbitux
- Norway · Erbitux
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9d4d8bd9-2424-4124-bc5c-e1e19ae31746 GET /v1/drugs/9d4d8bd9-2424-4124-bc5c-e1e19ae31746?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66843357",
"date_amm": "2007-02-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/04/281",
"substance": "CÉTUXIMAB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about cétuximab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.